Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
Abstract Complete removal of hepatitis B virus (HBV) DNA from nuclei is difficult by the current therapies. Recent reports have shown that a novel genome-editing tool using Cas9 with a single-guide RNA (sgRNA) system can cleave the HBV genome in vitro and in vivo. However, induction of a double-stra...
Enregistré dans:
Auteurs principaux: | Takeshi Kurihara, Takasuke Fukuhara, Chikako Ono, Satomi Yamamoto, Kentaro Uemura, Toru Okamoto, Masaya Sugiyama, Daisuke Motooka, Shota Nakamura, Masato Ikawa, Masashi Mizokami, Yoshihiko Maehara, Yoshiharu Matsuura |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6a0a9b8099f94b9897ea32cd37e0cdaf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Precise genome-wide base editing by the CRISPR Nickase system in yeast
par: Atsushi Satomura, et autres
Publié: (2017) -
Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase
par: Cinzia Cinesi, et autres
Publié: (2016) -
SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
par: Shota Yoshida, et autres
Publié: (2021) -
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
par: Tao Ye, et autres
Publié: (2021) -
Novel evidence of HBV recombination in family cluster infections in western China.
par: Bin Zhou, et autres
Publié: (2012)